Clinical Trials Browser

Phase 1 × Head and Neck Neoplasms × camrelizumab × Clear all

NCT04510818 2020-08-14

Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2)

Phase 1 Unknown

Head and Neck Neoplasms